Skip to main content
Contact Us
Subscribe
E-Edition
64°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
8
Next >
BMO Initiates Coverage On This Gene Editing Spearhead
June 17, 2022
Tickers
EDIT
NTLA
Tags
Initiation
Analyst Ratings
Market News
From
Benzinga
The Daily Biotech Pulse: Veru Seeks Emergency Use Nod For COVID-19 Therapy, Vincerx Cuts Workforce, Moderna Starts Dosing In Flu Vaccine Study
June 07, 2022
Tickers
ADVM
AIKI
DCTH
DNA
Tags
Biotech
Benzinga
PDSB
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
June 07, 2022
Tickers
AIKI
BAOS
BCAN
CETX
Tags
GTLB
GLBS
Today's Market
From
InvestorPlace
16 Stocks Moving in Tuesday's Pre-Market Session
June 07, 2022
Tickers
AERC
AUVI
BCAN
CETX
Tags
CETX
AERC
ENOB
From
Benzinga
Cathie Wood Is Selling Gene Editing Stocks. Here’s Why.
June 02, 2022
Tickers
ARKG
ARKK
BNR
DNA
Tags
EDIT
Today's Market
ARKG
From
InvestorPlace
Editas Medicine's Return On Capital Employed Insights
May 19, 2022
Tickers
EDIT
Tags
Market News
Benzinga
Earnings
From
Benzinga
Why Editas Medicine's Shares Fell 28.9% This Week
May 13, 2022
Tickers
CRSP
EDIT
NTLA
Tags
^IXIC
EDIT
Recent Press Releases
From
Motley Fool
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
May 13, 2022
Tickers
BBIO
BFRI
BMY
BTTX
Tags
EQRX
Benzinga
Biotech
From
Benzinga
These 5-Stock Samplers Have Gotten Whacked. And That's OK
May 13, 2022
Tickers
AAPL
ABNB
AMGN
AMZN
Tags
zoom
SE
AMZN
From
Motley Fool
Expert Ratings for Editas Medicine
May 09, 2022
Tickers
EDIT
Tags
Market News
Benzinga
BZI/AAR
From
Benzinga
Editas Medicine: Q1 Earnings Insights
May 04, 2022
Tickers
EDIT
Tags
EDIT
BZI/Recaps
News
From
Benzinga
Editas Medicine Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
Tickers
EDIT
Tags
Market News
EDIT
News
From
Benzinga
Editas Medicine's EDIT-301 receives FDA Rare Pediatric Disease designation for Beta Thalassemia
April 26, 2022
Tickers
EDIT
Tags
General
Small Cap
FDA
From
Benzinga
3 Ominous Reasons to Avoid This Biotech Pioneer
April 19, 2022
Tickers
CRSP
EDIT
NTLA
Tags
CRSP
NTLA
Recent Press Releases
From
Motley Fool
CRISPR Stocks Are Huge -- Here's Why They'll Get Even Bigger by 2030
April 13, 2022
Tickers
CRSP
EDIT
NTLA
VRTX
Tags
EDIT
Recent Press Releases
NTLA
From
Motley Fool
Who Benefits From Amazon's Stock Split?
March 16, 2022
Tickers
AAPL
AMZN
BMBL
CMG
Tags
Market News
CMG
AMZN
From
Motley Fool
Editas Medicine Stock Jumps As Patent Office Rules In Favor Of Broad's CRISPR Patents
March 01, 2022
Tickers
EDIT
Tags
Gene Editing
News
EDIT
From
Benzinga
The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution
March 01, 2022
Tickers
ABBV
AMRN
AMRS
AVID
Tags
IBB
FDA
VALN
From
Benzinga
27 Stocks Moving in Monday's Pre-Market Session
March 01, 2022
Tickers
AREB
ATXI
AVGR
AVIR
Tags
AVIR
SNII
AREB
From
Benzinga
Expert Ratings For Editas Medicine
February 25, 2022
Tickers
EDIT
Tags
EDIT
BZI/AAR
Analyst Ratings
From
Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
Tickers
ABCL
ADGI
AGIO
ARYD
Tags
EBS
General
ADGI
From
Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
Tickers
ABCL
AGIO
ARNA
ATXI
Tags
MRK
OTIC
VIR
From
Benzinga
51 Biggest Movers From Yesterday
February 09, 2022
Tickers
AA
ALJJ
AMZN
ANGH
Tags
UCL
KPTI
AA
From
Benzinga
Editas Suddenly Terminates Chief Medical Officer Without An Explanation
February 08, 2022
Tickers
EDIT
Tags
Trading Ideas
Health Care
News
From
Benzinga
35 Stocks Moving In Tuesday's Mid-Day Session
February 08, 2022
Tickers
AA
AMZN
ANGH
ANY
Tags
Benzinga
PFE
LDI
From
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Tickers
ALKS
AMGN
AXSM
BIIB
Tags
IBB
BXRX
KPTI
From
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 08, 2022
Tickers
ACHV
ATHE
ATNF
EDIT
Tags
Movers
Benzinga
KPTI
From
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 08, 2022
Tickers
AEYE
AMZN
ANGH
AREB
Tags
VLDR
SLQT
AREB
From
InvestorPlace
21 Stocks Moving in Tuesday's Pre-Market Session
February 08, 2022
Tickers
AMZN
ANY
AREB
ATHE
Tags
Penny Stocks
News
PPSI
From
Benzinga
2 Biotech Stocks That Could Skyrocket This Year
February 02, 2022
Tickers
EDIT
KRYS
Tags
EDIT
KRYS
Market News
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.